IL18 and acute myeloid leukemia: discovered that interleukin (IL)‐12, IL‐15 and IL‐18 induce memory‐like NK cells that exhibit augmented killing against AML, regardless of KIR‐ligand interactions, leading to an expanded NK cell pool of AML‐reactive effector cells.